In October the Society for Integrative Oncology (SIO) will host its 9th international conference in Albuquerque, NM. SIO President, Kara Kelly, MD, describes the agenda and discusses her thoughts on what the future holds for the practice of integrative oncology. The SIO's mission is to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer.
Kara Kelly, MD, is a professor of clinical pediatrics at Columbia University Medical Center. She has been with Columbia University since 1996, and throughout her career there she has been on the forefront of innovative research and clinical programing. She is the medical director of the Integrative Therapies Program for Children with Cancer at the Herbert Irving Child & Adolescent Oncology Center, and chair of the Hodgkin Lymphoma Committee of the Children's Oncology Group (COG) New York-Presbyterian/Morgan Stanley Children's Hospital. Kelly and her team were the first clinicians in the country to mainstream complementary and alternative medical therapies into a pediatric oncology setting. She is the author or coauthor of more than 100 articles and medical abstracts. She speaks all over the world about childhood cancer.